Variable efficacy of repetitive transcranial magnetic stimulation (rTMS) for tinnitus necessitates predictive biomarkers. Pre-treatment brain structural features may predict rTMS outcomes, given that tinnitus involves structural brain alterations and rTMS can induce neuroplastic changes. OBJECTIVE: To identify pre-treatment brain structural biomarkers predictive of rTMS efficacy in subjective tinnitus.
Pre-treatment structural brain imaging biomarkers show promise for predicting rTMS response in tinnitus, but this is a preliminary finding — clinicians should not use these biomarkers to guide rTMS patient selection until prospective validation in larger, independent cohorts is available.
Identifying reliable predictors of rTMS response could transform tinnitus treatment by enabling personalized selection of candidates, reducing ineffective interventions and their costs.
- 01Structural brain MRI biomarkers measured before rTMS treatment can predict tinnitus treatment response.
- 02Study is the first to link pre-treatment brain structure to rTMS outcomes in subjective tinnitus.
- 03Published in Frontiers in Neurology; design and sample size details are not fully disclosed.
- 04Could enable patient stratification before offering rTMS for tinnitus.
- 05Requires external validation before clinical adoption.
Pre-treatment structural brain biomarkers can predict response to rTMS in patients with subjective tinnitus.
studypartially supported- PMID
- 42422200
- DOI
- 10.3389/fneur.2026.1808769.
- Journal
- Frontiers in Neurology
- Publication type
- research_article
- Evidence level
- 4
- Population
- Patients with subjective tinnitus undergoing rTMS treatment
- Intervention
- Repetitive transcranial magnetic stimulation (rTMS) for subjective tinnitus
Primary outcomes
Prediction of rTMS treatment response using pre-treatment structural brain biomarkers; Identification of structural MRI features associated with tinnitus treatment outcomes